Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study is being done to determine whether levels of prostate cancer derived extracellular vesicles from blood and urine specimens correlate with response to primary local treatment (surgery) in prostate cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• PROSTATE CANCER PATIENTS:
‣ Age 18+
⁃ Able to give informed consent
⁃ Patients with prostate cancer
⁃ Patients treated with primary prostatectomy
∙ The focus will be on high-risk patients with at least one of either criterion:
⁃ PSA \>= 20 ng/ml
⁃ AND/OR Gleason \>= 8
⁃ AND/OR clinical stage \>= T3
• FEMALE CONTROL PATIENTS:
‣ Age 18+
⁃ Able to give informed consent
Locations
United States
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Clinical Trials Referral Office
mayocliniccancerstudies@mayo.edu
855-776-0015
Time Frame
Start Date: 2020-06-10
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 130
Treatments
Observational (Cohort I)
Prostate cancer patients undergo blood and urine sample collection on study. Patients' medical records are also reviewed.
Observational (Cohort III)
Female urology clinic patients and female volunteers undergo blood and urine sample collection on study.
Observational (Cohort II)
Prostate cancer patients undergo blood and urine sample collection throughout the study. Patients' medical records are also reviewed.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic